中国临床实用医学
中國臨床實用醫學
중국림상실용의학
CHINA CLINICAL PRACTICAL MEDICINE
2009年
5期
49-50
,共2页
鲁建军%巫国勇%徐桂兴%马俊%罗红鹤%钟佛添
魯建軍%巫國勇%徐桂興%馬俊%囉紅鶴%鐘彿添
로건군%무국용%서계흥%마준%라홍학%종불첨
非小细胞肺癌%孤立性脑转移瘤%伽玛刀
非小細胞肺癌%孤立性腦轉移瘤%伽瑪刀
비소세포폐암%고립성뇌전이류%가마도
Non-small-eel lung cancer%Isolated brain metastasis%Gamma-knife
目的 比较肺癌合并孤立性脑转移患者原发病灶切除及不同方法处理脑部转移灶的临床疗效.方法 回顾性分析2004年1月至2008年6月在中山大学附属第一医院收治的37例非小细胞肺癌合并孤立性脑转移的患者的临床资料,其中21例患者接受开颅摘除脑转移瘤+肺部原发灶的根治性切除治疗(开颅组);16例患者接受γ-刀照射脑转移瘤+肺部原发灶根治性切除治疗(γ-刀组).观察两组患者治疗后的中位生存时间和1年生存率情况.结果 中位随访时间20个月(18~26个月).开颅组和γ-刀组的中位生存时间分别为11.8个月和12.6个月,1年生存率分别为57.14%(12/21)和56.25%(9/16),但两组的生存曲线无统计学意义(P>0.05).结论 对于肺癌合并孤立性脑转移灶的患者应积极外科处理;至于脑部转移灶的处理,γ-刀的使用具有创伤小,疗程短的优越性.
目的 比較肺癌閤併孤立性腦轉移患者原髮病竈切除及不同方法處理腦部轉移竈的臨床療效.方法 迴顧性分析2004年1月至2008年6月在中山大學附屬第一醫院收治的37例非小細胞肺癌閤併孤立性腦轉移的患者的臨床資料,其中21例患者接受開顱摘除腦轉移瘤+肺部原髮竈的根治性切除治療(開顱組);16例患者接受γ-刀照射腦轉移瘤+肺部原髮竈根治性切除治療(γ-刀組).觀察兩組患者治療後的中位生存時間和1年生存率情況.結果 中位隨訪時間20箇月(18~26箇月).開顱組和γ-刀組的中位生存時間分彆為11.8箇月和12.6箇月,1年生存率分彆為57.14%(12/21)和56.25%(9/16),但兩組的生存麯線無統計學意義(P>0.05).結論 對于肺癌閤併孤立性腦轉移竈的患者應積極外科處理;至于腦部轉移竈的處理,γ-刀的使用具有創傷小,療程短的優越性.
목적 비교폐암합병고립성뇌전이환자원발병조절제급불동방법처리뇌부전이조적림상료효.방법 회고성분석2004년1월지2008년6월재중산대학부속제일의원수치적37례비소세포폐암합병고립성뇌전이적환자적림상자료,기중21례환자접수개로적제뇌전이류+폐부원발조적근치성절제치료(개로조);16례환자접수γ-도조사뇌전이류+폐부원발조근치성절제치료(γ-도조).관찰량조환자치료후적중위생존시간화1년생존솔정황.결과 중위수방시간20개월(18~26개월).개로조화γ-도조적중위생존시간분별위11.8개월화12.6개월,1년생존솔분별위57.14%(12/21)화56.25%(9/16),단량조적생존곡선무통계학의의(P>0.05).결론 대우폐암합병고립성뇌전이조적환자응적겁외과처리;지우뇌부전이조적처리,γ-도적사용구유창상소,료정단적우월성.
Objective To assess the therapeutic effect of non-sinai-cell lung cancer with isolated brain metastasis. Methods From January 2004 to June 2008, thirty-seven patients diagnosed as non-small-eel lung cancer with isolated cerebral metastasis received treatment in The First Affiliated Hospital of Sun Yet-sen Uni-versity. Some cases (21 peients)were treated with the craniotomy on brain metastasis and lung cancer resection, the other cases (16patients)were treated with the γ-ray stereotactic radiosurgery on brain metastasis and lung cancer resection. The median survival and one-year survival rate were analysed between the two groups. Results The cases were followed up for 18 to 26 months (median, 20 months). The median survival for craniotomygroup andγ-knffe group were 11.8 months and 12. 6 months, respectively,and the one-year survival rate were 57.14% ( 12/21 ) and 56. 25% ( 9/16), respectively ( P > 0. 05 ), while no significant difference was found be-tween the two curves of survival( P >0. 05 ). Conclusion The patients with non-smal-cell lung cancer with iso-lated brain metastases should be treated actively, meanwhile, it is mild trauma and short period of treatment that the isolated brain metastasis is treated with γ-knife.